Synthesis, hypoglycemic and aldose reductase inhibition activity of novel ferulic acid derivatives

Authors

  • Xianfeng Huang School of Pharmaceutical Engineering & Life Science, Changzhou University, Changzhou 213164, PR
  • Yuanyuan Liu School of Pharmaceutical Engineering & Life Science, Changzhou University, Changzhou 213164, PR
  • Cheng Zhang
  • Guoqiang Song School of Pharmaceutical Engineering & Life Science, Changzhou University, Changzhou 213164

DOI:

https://doi.org/10.7439/ijpc.v7i1.3798

Abstract

A novel class of ferulic acid derivatives with urea groups were synthesized and evaluated for hypoglycemic and aldose reductase inhibition activities. Several compounds showed comparable in vivo hypoglycemic agents to the commercial drug glibenclamide. Furthermore, of the tested compounds, 7a and 7 b displayed the most potent aldose reductase inhibitory activity in vitro , with an IC 50 of 0.55 and 3.88 M, respectively. Docking simulation was performed to insert compound 7a and 12a into the crystal structure of aldose reductase at active site to determine the probable binding model.

Downloads

Download data is not yet available.

Downloads

Published

2017-01-30

Issue

Section

Research Articles

How to Cite

1.
Synthesis, hypoglycemic and aldose reductase inhibition activity of novel ferulic acid derivatives. Int J of Pharm Chem [Internet]. 2017 Jan. 30 [cited 2026 Jan. 3];7(1):01-10. Available from: https://ssjournals.co.in/index.php/ijpc/article/view/3798